Dual block her2 assessment increased her2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from china

HIGHLIGHTS

• who: Chen Xu from the multicenter clinical trial from China have published the research work: Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China, in the Journal: (JOURNAL) of July/31,/2017
• what: It adversely affects the accuracy of HER2 assessment and is the main reason to get the false negative results . This study as well as the previous single-center studies provided solid evidence that dual block assessment can be served as a new reliable strategies to deal with the adverse . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.